James Larkin

Also affiliated with University of the Witwatersrand, Trinity College Dublin

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 18 papers. Top paper: “Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study”.

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Nature Cancer(2021)10.1038/s43018-021-00274-w

N/A

6.8DataRank · unranked

185 citations

Scott T.C. Shepherd, Lewis Au, Katalin A. Wilkinson, Mary Wu, Fiona Byrne +91 more

Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆

Annals of Oncology(2020)10.1016/j.annonc.2020.04.471

N/A

3.5DataRank · unranked

110 citations

Alexander N. Shoushtari, D Chauhan, David Palmieri, Belinda Lee, Maartje W. Rohaan +20 more

Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma

Cancer Cell(2023)10.1016/j.ccell.2023.03.010

N/A

2.2DataRank · unranked

82 citations

Meelad Amouzgar, Shannon M. Pfeiffer, Timothy R. Howes, Egmidio Medina, Michael J. Travers +14 more

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

New England Journal of Medicine(2015)10.1056/nejmoa1504030

N/A

1.3DataRank · unranked

8085 citations

Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C. Lance Cowey, Christopher D. Lao +35 more

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

New England Journal of Medicine(2012)10.1056/nejmoa1113205

N/A

1.3DataRank · unranked

7745 citations

Andrew J. Rowan, Stuart Horswell, James Larkin, David Endesfelder, Eva Gronroos +29 more

Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100781

N/A

1.1DataRank · unranked

26 citations

Scott T.C. Shepherd, Lewis Au, Mary Wu, Ruth Harvey, Katalin A. Wilkinson +59 more

Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions

Nature Genetics(2024)10.1038/s41588-024-01725-7

N/A

0.987DataRank · unranked

51 citations

Diptavo Dutta, Mitchell J. Machiela, Bryan R. Gorman, Timothy Winter, Dayne Okuhara +95 more

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial

Cancer(2020)10.1002/cncr.33033

N/A

0.875DataRank · unranked

340 citations

Bernard Escudier, Saby George, Hans J. Hammers, Sandhya Srinivas, Scott S. Tykodi +26 more

Safety of pembrolizumab for the treatment of melanoma

Expert Opinion on Drug Safety(2015)10.1517/14740338.2015.1021774

N/A

0.542DataRank · unranked

36 citations

Tiana Kordbacheh, James Larkin, Juan Martin-Liberal

Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003743

N/A

0.542DataRank · unranked

36 citations

Charlene Mantia, Lillian Werner, Ahmad A. Tarhini, James Larkin, F. Stephen Hodi +10 more

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer

Cancer Cell(2023)10.1016/j.ccell.2023.04.005

N/A

0DataRank · unranked

10 citations

Scott T.C. Shepherd, Annika Fendler, Edward J Carr, Lewis Au, Ruth Harvey +61 more

Association of circulating tumor DNA kinetics with disease recurrence in patients with stage IIIB/C/IV melanoma treated with adjuvant immunotherapy in Checkmate 238.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9577

N/A

0DataRank · unranked

6 citations

Jennifer Wiggins, Josephine Alegun, Saim Ali, Hao Tang, Sheen Wang +10 more

Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases

Human Molecular Genetics(2022)10.1093/hmg/ddac089

N/A

0DataRank · unranked

36 citations

Avgi Andreou, Laia Bassaganyas, Alexey A. Larionov, Alex J. Cornish, Daniel Chubb +11 more

Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101435

N/A

0DataRank · unranked

20 citations

Richard Marais, Núria Porta, David González de Castro, Lisa Parsons, Christina Messiou +18 more

Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinoma

The American Journal of Human Genetics(2024)10.1016/j.ajhg.2024.07.012

N/A

0DataRank · unranked

10 citations

Xinyu Guo, Timothy Winter, Om Jahagirdar, Mark P. Purdue, Mitchell J. Machiela +93 more

Fatal intracranial haemorrhage shortly after belzutifan initiation in von Hippel–Lindau (VHL) disease-associated haemangioblastoma

ESMO Open(2025)10.1016/j.esmoop.2025.105109

N/A

0DataRank · unranked

3 citations

Christian Kelly‐Morland, S Drage, Angela F. Brady, R. Macwana, Lisa Pickering +4 more

Using Mendelian randomization to investigate etiologic heterogeneity across renal cell carcinoma subtypes

International Journal of Epidemiology(2025)10.1093/ije/dyaf177

N/A

0DataRank · unranked

1 citations

Om Jahagirdar, Mark P. Purdue, Diptavo Dutta, Mitchell J. Machiela, Bryan R. Gorman +94 more

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

The Lancet(2022)10.1016/s0140-6736(22)00147-7

N/A

0DataRank · unranked

67 citations

Scott T C Shepherd, Lewis Au, Mary Wu, Ruth Harvey, Andreas M Schmitt +56 more